InsidersTradesSigma
Track the Hansoh Pharmaceutical Group Co. Ltd. stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Operating in the Health Care sector, Hansoh Pharmaceutical Group Co. Ltd. has recorded 9 public disclosures. Market capitalisation: €195.5bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: Lyu Aifeng. All data is free.
9
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€4m
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Hansoh Pharmaceutical Group Co. Ltd. Strong Buy (bullish), based on 22 analysts. Average price target: HK$46.49.
28Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,248 of 29,064 companies
65.9
score / 100
Value39
Quality93
FCF yld3.0%
Earn yld2.7%
EV/EBITDA30.0x
ROE19%
Gross mgn90%
Net mgn37%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
Declarations9 total
86,679 shares@ HK$3.3790.0002% mcap2.3% of flowShareXHKGHKEX:DA20260630E00154
9,631 sharesShareXHKGHKEX:DA20260630E00153
27,005 sharesShareXHKGHKEX:DA20260430E00532
109,010 sharesShareXHKGHKEX:DA20260430E00527
64,845 shares@ HK$4.5730.0001% mcap2.3% of flowShareXHKGHKEX:DA20260430E00535
178,200 shares@ HK$2.840.0002% mcap4.0% of flowShareXHKGHKEX:DA20260430E00533
300,000 shares@ HK$39.69890.0056% mcap93.6% of flowShareXHKGHKEX:DA20260423E00042
9 of 9 declarations
关于 Hansoh Pharmaceutical Group Co. Ltd.
翰森制药集团有限公司是一家中国公司，从事药品的研发和制造。它主要专注于肿瘤、精神疾病和传染病领域。